Biocon to set up R&D unit in Telangana

Image
Press Trust of India Hyderabad
Last Updated : Feb 23 2018 | 10:10 PM IST
Bio-pharmaceuticals firm Biocon will soon start an R&D lab of its subsidiary Syngene in Genome Valley in Telangana, which is expected to generate 1,000 high-tech jobs, the state government said today.
The company will also be expanding its current presence in Hyderabad on APIs (Active Pharmaceutical Ingredients/ Intermediates) to add 500 new jobs, it added.
Biocon MD Kiran Mazumdar-Shaw met Telangana IT and Industries Minister K T Rama Rao on the sidelines of BioAsia 2018 and informed the minister about Biocon's decision to expand their operations in Telangana, the statement said.
A business delegation headed byChutima Bunyapraphasara, Deputy Minister of Commerce, Thailand, also met Rao on the sidelines of BioAsia 2018.
Further, Italian Consul General in Mumbai, Stefania Costanza, informed Rao that a delegation of the Italian Chamber of Commerce will soon visit Telangana to explore business opportunities, the statement added.
The minister also met Terri Bresenham, CEO & President, Sustainable Healthcare Division, GE. The GE team expressed interest in collaborating with the Telangana Academy of Skill & Knowledge (TASK) in healthcare skilling, the release added.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 23 2018 | 10:10 PM IST

Next Story